Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets

An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters

(2023) Shaofeng Deng et al.   Nature Communications

Next generation live-attenuated influenza vaccine platforms

(2022) Subhan Ullah et al.   Expert Review of Vaccines

Human infection with avian-origin H5N6 influenza a virus after exposure to slaughtered poultry

(2022) Jun Li et al.   Emerging Microbes & Infections

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2

(2022) Junyu Chen et al.   Science Bulletin

Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray

(2021) Rafael R. de Assis et al.   Nature Communications

Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay

(2021) Zhu-Nan Li et al.   mBio

Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model

(2021) Ekaterina Stepanova et al.   Microorganisms

Isolation of clade 2.3.4.4b A(H5N8), a highly pathogenic avian influenza virus, from a worker during an outbreak on a poultry farm, Russia, December 2020

(2021) Olga G Pyankova et al.   Eurosurveillance

Emerging H5N8 avian influenza viruses

(2021) Weifeng Shi et al.   SCIENCE

Antigenic evolution of contemporary clade 2.3.4.4 HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control

(2021) Nicola S Lewis et al.   VACCINE

Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge

(2021) Daria Mezhenskaya et al.   Viruses-Basel

OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza

(2021) Judith Del Campo et al.   Frontiers in Immunology

Animal Models Utilized for the Development of Influenza Virus Vaccines

(2021) Ericka Kirkpatrick Roubidoux et al.   Vaccines

Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model

(2021) Weiyang Sun et al.   Viruses-Basel

Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses

(2020) Reina Yamaji et al.   REVIEWS IN MEDICAL VIROLOGY

Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 — Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines

(2020) E. V. Krutikova et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Live Attenuated Cold-Adapted Influenza Vaccines

(2020) Kanta Subbarao   Cold Spring Harbor Perspectives in Medicine

Influenza-Specific Lung-Resident Memory CD8+ T Cells

(2020) Stephanie van de Wall et al.   Cold Spring Harbor Perspectives in Biology

Recombinant influenza A viruses as vaccine vectors

(2019) Thomas Gerlach et al.   Expert Review of Vaccines

A case of reassortant seasonal influenza A(H1N2) virus, Denmark, April 2019

(2019) Ramona Trebbien et al.   Eurosurveillance

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge

(2019) Irina Isakova-Sivak et al.   Vaccines

Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children

(2019) P. J. Turner et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Multiple adaptive amino acid substitutions increase the virulence of a wild waterfowl-origin reassortant H5N8 avian influenza virus in mice

(2018) Zhijun Yu et al.   VIRUS RESEARCH

Immune responses after live attenuated influenza vaccination

(2018) Kristin G.-I. Mohn et al.   Human Vaccines & Immunotherapeutics

Influenza

(2018) Florian Krammer et al.   Nature Reviews Disease Primers

Repeated Antigen Exposure Extends the Durability of Influenza-Specific Lung-Resident Memory CD8+ T Cells and Heterosubtypic Immunity

(2018) Natalija Van Braeckel-Budimir et al.   Cell Reports

Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine

(2018) Daniil Korenkov et al.   Expert Review of Vaccines

Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness

(2018) Ju Hwan Jeong et al.   VACCINE

Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2–49years

(2017) Roger Baxter et al.   VACCINE

Avian Influenza H5N6 Viruses Exhibit Differing Pathogenicities and Transmissibilities in Mammals

(2017) Zongzheng Zhao et al.   Scientific Reports

Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus

(2016) Rusheng Zhang et al.   INFECTION GENETICS AND EVOLUTION

Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus

(2016) Bin Zhou et al.   JOURNAL OF VIROLOGY

Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses

(2016) Hyon-Xhi Tan et al.   VACCINE

Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial

(2016) W Abdullah Brooks et al.   Lancet Global Health

The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893–2014

(2015) A. Sally Davis et al.   ANTIVIRAL RESEARCH

Novel reassortant influenza viruses between pandemic (H1N1) 2009 and other influenza viruses pose a risk to public health

(2015) Weili Kong et al.   MICROBIAL PATHOGENESIS

Fatal H5N6 Avian Influenza Virus Infection in a Domestic Cat and Wild Birds in China

(2015) Zhijun Yu et al.   Scientific Reports

Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses

(2014)   Influenza and Other Respiratory Viruses

Influenza A and B Virus Intertypic Reassortment through Compatible Viral Packaging Signals

(2014) S. F. Baker et al.   JOURNAL OF VIROLOGY

Cold adaptation improves the growth of seasonal influenza B vaccine viruses

(2014) Hyunsuh Kim et al.   VACCINE

The role of nasal IgA in children vaccinated with live attenuated influenza vaccine

(2012) Christopher S. Ambrose et al.   VACCINE

A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus Strains

(2011) R. Hai et al.   JOURNAL OF VIROLOGY

A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus

(2011) Byron E. E. Martina et al.   PLoS One

PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus

(2009) I. V. Kiseleva et al.   JOURNAL OF GENERAL VIROLOGY